IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.3670
-0.1131 (-23.56%)
At close: Jan 23, 2026, 4:00 PM EST
0.3528
-0.0142 (-3.87%)
After-hours: Jan 23, 2026, 7:59 PM EST
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $26.41 million as of January 23, 2026. Its market cap has decreased by -55.47% in one year.
Market Cap
26.41M
Enterprise Value
13.86M
1-Year Change
-55.47%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $26.41M, a decrease of -92.85%. That is a compound annual growth rate of -46.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 26.41M | -39.73% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
| Nov 5, 2021 | 369.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 16.62M |
| Citius Pharmaceuticals | 16.61M |
| Hoth Therapeutics | 16.29M |
| AEON Biopharma | 16.10M |
| Cellectar Biosciences | 15.48M |
| Applied Therapeutics | 15.46M |
| Moleculin Biotech | 14.66M |
| Cocrystal Pharma | 14.34M |